scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJMOA0807986 |
P698 | PubMed publication ID | 19458363 |
P50 | author | Madhu K Natarajan | Q89024080 |
David P Faxon | Q114292261 | ||
Hans-Jürgen Rupprecht | Q114444128 | ||
Sanjit S Jolly | Q114453049 | ||
Salim Yusuf | Q2214381 | ||
Petr Widimský | Q12045089 | ||
Philippe Gabriel Steg | Q16027739 | ||
Alvaro Avezum | Q48865428 | ||
William E Boden | Q60503412 | ||
Christopher B. Granger | Q62050240 | ||
Keith Fox | Q72227369 | ||
Susan Chrolavicius | Q82040593 | ||
Jean-Pierre Bassand | Q82062172 | ||
Shamir Mehta | Q87398837 | ||
P2093 | author name string | Jun Zhu | |
Rizwan Afzal | |||
Craig Horsman | |||
Jacques Col | |||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | acute coronary syndrome | Q266018 |
P1104 | number of pages | 11 | |
P304 | page(s) | 2165-2175 | |
P577 | publication date | 2009-05-21 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Early versus Delayed Invasive Intervention in Acute Coronary Syndromes | |
P478 | volume | 360 |
Q37965481 | 2011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician. |
Q37953885 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
Q22241922 | 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines |
Q53796787 | 2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Heart Disease. |
Q37647504 | 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group |
Q39952939 | A Dutch perspective on the ESC/EACTS guidelines on myocardial revascularisation |
Q45896046 | A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial |
Q48510946 | A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction |
Q61450633 | A phase 1, first-in-human study of F-GP1 positron emission tomography for imaging acute arterial thrombosis |
Q48206499 | A portable prototype magnetometer to differentiate ischemic and non-ischemic heart disease in patients with chest pain |
Q92971778 | Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals |
Q37789014 | Acute coronary syndrome update for hospitalists |
Q48659761 | Acute coronary syndrome. A diffuse diagnosis |
Q38168182 | Acute coronary syndrome: optimising management through risk assessment |
Q88960063 | Acute coronary syndromes |
Q30490718 | Acute coronary syndromes: diagnosis and management, part I |
Q37638627 | Acute coronary syndromes: selective vs early invasive strategies |
Q48368949 | Acute kidney injury requiring dialysis and in-hospital mortality in patients with chronic kidney disease and non-ST-segment elevation acute coronary syndrome undergoing early vs delayed percutaneous coronary intervention: A nationwide analysis |
Q26783157 | Acute management of unstable angina and non-ST segment elevation myocardial infarction |
Q30248576 | Acute myocardial infarction |
Q38813299 | An update on management of the patient presenting with non-ST-elevation acute coronary syndromes |
Q50864337 | Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group". |
Q58920107 | Antithrombotic Therapy in Patients with Acute Coronary Syndromes: Biological Markers and Personalized Medicine |
Q41265453 | Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome. |
Q36714117 | Area Median Income and Metropolitan Versus Nonmetropolitan Location of Care for Acute Coronary Syndromes: A Complex Interaction of Social Determinants |
Q24288920 | Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal |
Q64924978 | Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome. |
Q26801639 | B Cells and Functional Antibody Responses to Combat Influenza |
Q84544342 | Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI! |
Q38059154 | Biomarkers in acute coronary artery disease |
Q54624187 | Biomarkers in the triage of chest pain: are we making progress? |
Q38423493 | Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice? |
Q46046218 | Cangrelor: a new CHAMPION for percutaneous coronary intervention |
Q36911023 | Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome |
Q42139860 | Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury |
Q61807901 | Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015 |
Q40865080 | Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study |
Q28383967 | Clinical outcome of veterans with acute coronary syndrome who had been exposed to agent orange |
Q53644963 | Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization. |
Q48186817 | Clinical presentation of patients with spontaneous coronary artery dissection. |
Q33595369 | Comparative clinical implications of admission electrocardiographic findings for patients with non-ST-segment elevation myocardial infarction |
Q92564333 | Comparison of early and delayed invasive strategies in short-medium term among patients with non-ST segment elevation acute coronary syndrome: A systematic review and meta-analysis |
Q90701411 | Comparison of enoxaparin and unfractionated heparin in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis |
Q42853394 | Comparison of immediate vs early invasive strategy in patients with first acute non-ST-elevation myocardial infarction |
Q35017307 | Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention |
Q30575258 | Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry |
Q42716722 | Composite risk scores for acute coronary syndromes |
Q37765146 | Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2). |
Q50575232 | Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study. |
Q36214892 | Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014. |
Q37377798 | Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort |
Q38049328 | Current state of the performance of percutaneous coronary intervention in centres without on-site cardiac surgery |
Q48021754 | Danish trends in pharmacotherapy, comorbidities, and demographics in patients referred for coronary angiography: what changed during a decade? |
Q38245287 | Decade in review--acute coronary syndromes: Successes and future objectives in acute coronary syndrome |
Q92961510 | Derivation and Validation of a Novel Cardiac Intensive Care Unit Admission Risk Score for Mortality |
Q38347336 | Developments in Oral Antiplatelet Agents for the Treatment of Acute Coronary Syndromes: Clopidogrel, Prasugrel, and Ticagrelor |
Q35017934 | Discrepancy between clinician and research assistant in TIMI score calculation (TRIAGED CPU) |
Q47613575 | Discrimination of patients with type 2 myocardial infarction |
Q36559522 | Does T wave inversion in lead aVL predict mid-segment left anterior descending lesions in acute coronary syndrome? A retrospective study |
Q42917584 | Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial |
Q38896245 | Early Invasive Strategy and In-Hospital Survival Among Diabetics With Non-ST-Elevation Acute Coronary Syndromes: A Contemporary National Insight. |
Q36974390 | Early Invasive Strategy for Unstable Angina: a New Meta-Analysis of Old Clinical Trials |
Q36319844 | Early diagnosis of acute myocardial infarction using high-sensitivity troponin I |
Q44384417 | Early invasive strategy and outcomes of non-ST-elevation acute coronary syndrome patients: is time really the major determinant? |
Q40771637 | Early invasive versus early conservative strategy in non-ST-elevation acute coronary syndrome: An outcome research study. |
Q44823803 | Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. |
Q48198112 | Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial. |
Q38001384 | Early versus delayed percutaneous coronary intervention for patients with non-ST segment elevation acute coronary syndrome: a meta-analysis of randomized controlled clinical trials |
Q47848413 | Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study |
Q37832057 | Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies |
Q53590491 | Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction. |
Q37140992 | Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines? |
Q46810982 | Estimation of a decreasing hazard of patients with acute coronary syndrome |
Q51731741 | Evaluating the optimal timing of revascularisation in patients with transient ST-segment elevation myocardial infarction: rationale and design of the TRANSIENT Trial. |
Q49887605 | Examination of the appropriate timing of reperfusion therapy for recent myocardial infarction: a Japanese single-center retrospective study |
Q40793052 | Frailty is a short-term prognostic marker in acute coronary syndrome of elderly patients. |
Q38647581 | GDF-15 predicts cardiovascular events in acute chest pain patients. |
Q38602893 | Gender differences in outcomes in patients with acute coronary syndrome in the current era: A review |
Q88709430 | German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock |
Q37942701 | Glycoprotein IIb-IIIa inhibitors |
Q30486060 | High incidence of acute coronary occlusion in patients without protocol positive ST segment elevation referred to an open access primary angioplasty programme |
Q98386250 | High sensitivity troponin measurement in critical care: Flattering to deceive or 'never means nothing'? |
Q47772072 | High sensitivity troponins in contemporary cardiology practice: are we turning a corner? |
Q36769832 | High-sensitive cardiac troponin T |
Q93337831 | High-sensitivity cardiac troponin assays: finally ready for prime time? |
Q37926596 | High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department |
Q27007551 | High-sensitivity troponin assays: evidence, indications, and reasonable use |
Q37448857 | Hospital length of stay in patients with non-ST-segment elevation myocardial infarction |
Q35714803 | Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay |
Q47138841 | Immediate/Early vs. Delayed Invasive Strategy for Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review and Meta-Analysis |
Q26774723 | Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of 100 Studies |
Q38683249 | Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer |
Q64067114 | In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Interventi |
Q41232859 | In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure. |
Q43592490 | Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy |
Q37481596 | Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes |
Q39772400 | Inefficacy interim monitoring procedures in randomized clinical trials: the need to report |
Q37399613 | Influence of the Timing of Percutaneous Coronary Intervention on Clinical Outcomes in Non-ST-Elevation Myocardial Infarction |
Q47742517 | Is there a role for myocardial perfusion imaging in patients with an elevated high-sensitivity troponin? |
Q85042544 | Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome |
Q93208447 | Management of Acute Myocardial Infarction During the COVID-19 Pandemic |
Q37984773 | Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment |
Q39314230 | Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome |
Q97524590 | Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine |
Q66684648 | Mental health reform fails |
Q42336179 | Merits of Invasive Strategy in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome |
Q41725140 | Nationwide trends in use and timeliness of diagnostic coronary angiography in acute coronary syndromes from 2005 to 2011: Does distance to invasive heart centres matter? |
Q35140435 | Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats |
Q37041708 | Non-ST elevation myocardial infarction (NSTEMI) in three hospital settings in South Africa: does geography influence management and outcome? A retrospective cohort study |
Q35026325 | Non-ST-elevation myocardial infarction in the United States: contemporary trends in incidence, utilization of the early invasive strategy, and in-hospital outcomes |
Q36185831 | Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification |
Q36819302 | Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS) |
Q58812220 | Nurse-led Early Triage (NET) study of chest pain patients: a long term evaluation study of a service development aimed at improving the management of patients with non-ST-elevation acute coronary syndromes |
Q90608191 | Optimal Timing of Invasive Coronary Angiography following NSTEMI |
Q38640097 | Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. |
Q37780031 | Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes |
Q55204798 | Optimal treatment of patients with NSTE-ACS in the Dutch health care system. |
Q50864248 | Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b |
Q38542096 | P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal use |
Q47105918 | Patient perspectives on engagement in decision-making in early management of non-ST elevation acute coronary syndrome: a qualitative study. |
Q37561885 | Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome |
Q37900509 | Percutaneous coronary interventions in facilities without cardiac surgery on site |
Q37782048 | Periprocedural Myocardial Infarction: Review and Classification |
Q64120111 | Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects |
Q57482922 | Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: Insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial |
Q48096262 | Pre-hospital transthoracic echocardiography for early identification of non-ST-elevation myocardial infarction in patients with acute coronary syndrome. |
Q40207226 | Prediction of Angiographic Extent of Coronary Artery Disease on the Basis of Clinical Risk Scores in Patients of Unstable Angina |
Q44425116 | Prevalence and interventional outcomes of patients with resolution of ST-segment elevation between prehospital and in-hospital ECG. |
Q53591620 | Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin. |
Q37027861 | Reducing time to angiography and hospital stay for patients with high-risk non-ST-elevation acute coronary syndrome: retrospective analysis of a paramedic-activated direct access pathway |
Q55496702 | Regional to tertiary inter-hospital transfer versus in-house percutaneous coronary intervention in acute coronary syndrome. |
Q22241917 | Reperfusion Strategies in Acute Coronary Syndromes |
Q99615004 | Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome |
Q38009702 | Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization? |
Q26769732 | Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment |
Q57482608 | Risk stratification in non-ST elevation acute coronary syndromes: searching for the right formula |
Q26471900 | Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era |
Q37951403 | Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes. |
Q37967491 | Routine invasive versus conservative management strategies in acute coronary syndrome: time for a "hybrid" approach |
Q36116996 | SBC guidelines on unstable angina and non-ST-elevation myocardial infarction: executive summary |
Q42942498 | STEMI or non-STEMI: that is the question |
Q36988007 | Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers. |
Q31003983 | Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network. |
Q38097508 | Selection and timing for invasive therapy in non-ST-segment-elevation acute coronary syndrome. |
Q40571070 | Socio-economic position and time trends in invasive management and case fatality after acute myocardial infarction in Denmark |
Q90094277 | Temporal Pattern of CABG and PCI after Non-ST Elevation Myocardial Infarction Among Elderly Patients from NHDS |
Q61446637 | Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S |
Q36367018 | The 2012 ACCF/AHA Focused Update of the Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Guideline: a critical appraisal |
Q58696046 | The Effects of Geography on Outcomes of Routine Early Versus Selective Late Revascularization Strategy in the Treatment of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Transatlantic Randomized Controlled Tria |
Q31086486 | The Relation between the Timing of Percutaneous Coronary Intervention and Outcomes in Patients with Acute Coronary Syndrome with Routine Invasive Strategy - Data from Taiwan Acute Coronary Syndrome Full Spectrum Data Registry. |
Q50055934 | The Usefulness and Limitations of Point-of-care Cardiac Troponin Measurement in the Emergency Department |
Q89912295 | The impact of an acute chest pain pathway on the investigation and management of cardiac chest pain |
Q58819403 | The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI |
Q42320940 | The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: early invasive strategy for all? |
Q37947959 | The management of thrombotic lesions in the cardiac catheterization laboratory |
Q38171867 | The role of computed tomography in cardiovascular imaging: from X-ray department to emergency room. |
Q84638957 | The role of heart-type fatty acid-binding protein in predicting properties of coronary atherosclerosis in patients with acute coronary syndrome |
Q38375641 | Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2-Hour Infusion in High-Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention |
Q34441191 | Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients |
Q38100602 | Timing of angiography in non-ST elevation myocardial infarction |
Q50017162 | Timing of coronary angioplasty in patients with non-ST-segment elevation acute coronary syndromes. |
Q37946393 | Timing of early invasive intervention in patients with moderate to high risk acute coronary syndromes |
Q47106446 | Timing of invasive strategy in patients with non-ST-segment elevation acute coronary syndrome and effect on clinical outcomes. |
Q50017119 | Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART study |
Q88687563 | Timing of revascularisation for acute coronary syndrome |
Q40206567 | Towards a reappraisal of the TACTICS TIMI 18 trial in the era of modern pharmacological and interventional therapies |
Q47097300 | Treatment of acute myocardial infarction in the sub-arctic region of Norway. Do we offer an equal quality of care? |
Q64284601 | Treatment patterns of non-ST-elevation acute coronary syndrome patients presenting at non-PCI centres in the Netherlands and possible logistical consequences of adopting same-day transfer to PCI centres: a registry-based evaluation |
Q50732528 | Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003-2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). |
Q37517246 | Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark |
Q35196125 | Troponin elevation in acute ischemic stroke (TRELAS)--protocol of a prospective observational trial |
Q38837406 | Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome |
Q37972109 | Unstable angina and non-ST elevation myocardial infarction |
Q43133216 | Update on interventional cardiology |
Q90471261 | Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a 'real world' prospective registry |
Q37760095 | What goes into a major acute coronary syndrome trial and what will future trials look like? |
Q28072343 | When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome? |
Q88991681 | [Cardiac causes of chest pain] |
Q86643067 | [ESC guidelines 2015. Non-ST-elevation acute coronary syndrome] |
Q83179013 | [Ischemic heart disease: 2009 update] |
Q82334758 | [The length of hospital stay in patients with acute coronary syndrome is reduced by establishing a chest pain unit] |
Q87370707 | [Timing of invasive treatment in NSTEMI: as fast as in STEMI?] |
Q83320619 | [Update in interventional cardiology] |
Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
Q26774798 | 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteri |
Q22242895 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el |
Search more.